泰格医药(03347)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

03347 泰格医药

休市中 09-04 16:08:03

39.700

-0.100

-0.25%

最高40.380	最低39.360	成交量101.39万
今开40.340	昨收39.800	日振幅2.56%
总市值341.82亿	流通市值48.88亿	总股本8.61亿
成交额4,029万	换手率0.82%	流通股本1.23亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"03347","market":"HK","secType":"STK","nameCN":"泰格医药","latestPrice":39.7,"timestamp":1788509283006,"preClose":39.8,"halted":0,"volume":1013919,"delay":0,"changeRate":-0.002512562814070209,"floatShares":123124800,"shares":861000000,"eps":1.215597653922153,"marketStatus":"休市中","change":-0.1,"latestTime":"09-04 16:08:03","open":40.34,"high":40.38,"low":39.36,"amount":40294452,"amplitude":0.025628,"askPrice":39.7,"askSize":200,"bidPrice":39.66,"bidSize":600,"shortable":3,"etf":0,"ttmEps":0.1241686249725559,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788744600000},"marketStatusCode":7,"adr":0,"listingDate":1596729600000,"exchange":"SEHK","adjPreClose":39.8,"dividendRate":0.003667,"openAndCloseTimeList":[[1788485400000,1788494400000],[1788498000000,1788508800000]],"volumeRatio":0.440416,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"300347","market":"SZ","secType":"STK","nameCN":"泰格医药","latestPrice":50,"timestamp":1788505200000,"preClose":50.61,"halted":0,"volume":8125100,"delay":0,"premium":"-32.07"}},"requestUrl":"/m/hq/s/03347/wiki","defaultTab":"wiki","newsList":[{"id":"1139732809","title":"泰格医药：Massachusetts Financial Services Company减持，好仓比例降至6.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=1139732809","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1139732809?lang=zh_cn&edition=full","pubTime":"2026-09-04 17:23","pubTimestamp":1788513800,"startTime":"0","endTime":"0","summary":"Massachusetts Financial Services Company于2026年9月1日以每股均价39.7164港元卖出泰格医药股份14.84万股，涉资约589.39万港元。Massachusetts Financial Services Company此次减持前持有泰格医药好仓875.60万股，占比7.11%；减持后持股量为860.76万股，好仓比例降至6.99%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f7700173111443e192ac74957e46cb69","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196871140","title":"泰格医药拟回购A股不超过已发行股份总数10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1196871140","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196871140?lang=zh_cn&edition=full","pubTime":"2026-09-03 18:02","pubTimestamp":1788429776,"startTime":"0","endTime":"0","summary":"杭州泰格医药科技股份有限公司近日公告称，拟在适当情形下由股东大会及类别股东大会审议授权董事会以一般性授权方式回购公司已在香港联合交易所有限公司上市的A股股份，回购规模不超过董事会特别决议通过当日已发行A股总面值的10%。公司公告显示，截至最后实际可行日，泰格医药的已发行股份总数为861,026,050股，其中A股合计737,901,250股，H股合计123,124,800股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"泰格医药拟回购A股不超过已发行股份总数10%","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143583745","title":"泰格医药（03347）拟9月23日召开2026年第三次H股类别股东大会 审议股份回购及减资等议案","url":"https://stock-news.laohu8.com/highlight/detail?id=1143583745","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143583745?lang=zh_cn&edition=full","pubTime":"2026-09-03 18:02","pubTimestamp":1788429769,"startTime":"0","endTime":"0","summary":"上述两项为特别决议案，需获出席会议H股股东所持表决权不少于三分之二通过。会议预计时长不超过半天。股东及代理人需自理交通、食宿，并携带有效身份证明文件。详情见公司2026年9月3日发布的通函（）。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131961955","title":"泰格医药（03347）将于9月23日召开第三次临时股东大会审议募资用途变更及股权激励等七项议案","url":"https://stock-news.laohu8.com/highlight/detail?id=1131961955","media":"公告速递","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1131961955?lang=zh_cn&edition=full","pubTime":"2026-09-03 18:02","pubTimestamp":1788429753,"startTime":"0","endTime":"0","summary":"杭州泰格医药科技股份有限公司公告称，公司计划于2026年9月23日（周三）15:00在杭州市滨江区浦沿街道陆家潭街508号6楼会议室召开2026年第三次临时股东大会，A股及H股股东将按同一类别行使表决权。公司将自9月18日至23日暂停办理H股过户登记。会议以现场投票方式表决，股东可委托代理人出席。1）普通决议：变更H股发行募集资金用途；4）授予董事会回购A股的一般授权；7）授权董事会办理限制性股票激励计划相关事宜。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664852003","title":"泰格医药（300347）披露回购公司股份进展公告，9月1日股价下跌2.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664852003","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664852003?lang=zh_cn&edition=full","pubTime":"2026-09-01 22:19","pubTimestamp":1788272391,"startTime":"0","endTime":"0","summary":"截至2026年9月1日收盘，泰格医药报收于51.4元，较前一交易日下跌2.63%，最新总市值为442.57亿元。该股当日开盘52.5元，最高52.61元，最低51.06元，成交额达6.42亿元，换手率为2.19%。公告显示，截至2026年8月31日，泰格医药通过集中竞价交易方式回购股份20,963,478股，占公司总股本的2.4347%，占A股总股本的2.8410%。本次回购符合公司回购方案及相关法律法规要求。公司后续将在回购期限内继续实施回购计划，并按规定履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100042875.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03347","BK0077","BK1141","BK1583","300347","BK0028","LU1146622755.USD","BK1576","BK0174","LU1820825898.SGD","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127258879","title":"泰格医药(03347)披露回购进展：截至8月底已耗资约8.24亿元回购逾2096万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1127258879","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127258879?lang=zh_cn&edition=full","pubTime":"2026-09-01 17:34","pubTimestamp":1788255287,"startTime":"0","endTime":"0","summary":"2026年9月1日，泰格医药科技股份有限公司发布公告，披露公司股份回购的最新进展。根据此前于2026年5月13日及6月9日通过的相关决议，公司计划以自有或自筹资金回购部分A股股份，用于后续实施股权激励、员工持股或注销减少注册资本。公告显示，截至2026年8月31日，公司已通过集中竞价方式回购20,963,478股，占公司当前总股本的2.4347%，占A股总股本的2.8410%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663077168","title":"Schroders PLC增持泰格医药(03347)42.86万股 每股作价约40.26港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2663077168","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663077168?lang=zh_cn&edition=full","pubTime":"2026-08-31 19:10","pubTimestamp":1788174636,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，8月27日，Schroders PLC增持泰格医药(03347)42.86万股，每股作价40.2586港元，总金额约为1725.48万港元。增持后最新持股数目为880.61万股，最新持股比例为7.15%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489632.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1146622755.USD","BK0216","BK1583","03347","BK0028","EWH","BK0077","BK1576","LU1820825898.SGD","300347","BK1141","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663700790","title":"“真金白银”彰显发展信心 深市公司回购计划高质量落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2663700790","media":"经济参考网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663700790?lang=zh_cn&edition=full","pubTime":"2026-08-31 18:56","pubTimestamp":1788173760,"startTime":"0","endTime":"0","summary":"统计显示，截至目前，深市已有93家公司完成回购计划，累计回购金额达240.70亿元，较回购计划下限超出46.49%，占回购上限的83.50%；另有197项回购计划处于实施阶段，已回购金额合计177.60亿元。7月21日，公司披露股份回购方案，拟回购金额为4.5亿元至9亿元。7月30日，公司又推出新一轮上限为10亿元的回购计划。截至8月3日，公司公告累计回购金额已达1.4亿元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-31/doc-iniqfkkp7206777.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1969619763.USD","IE0008368742.USD","BK0077","IE00B97KM107.HKD","BK0108","LU0862451837.USD","000725","LU2580892789.USD","BK0045","000333","LU0405327148.USD","BK0061","IE0003851619.USD","BK0028","IE00B067MR52.USD","LU0593848301.USD","00300","BK0033","LU0572940350.SGD","300124","IE00B29SXG58.USD","LU1820825898.SGD","BK0130","BK0026","LU1934453819.USD","LU2495084118.USD","LU0898667661.SGD","LU0210527791.USD","LU2097828474.EUR","LU0572939691.SGD","BK0187","IE00B8L5B284.USD","LU0269904917.USD","LU0052750758.USD","IE00BKZH1Z71.USD","BK0109","LU2097828805.USD","BK0196","LU1781817850.SGD","IE00B031J352.USD","LU0456842615.SGD","IE00B031HW06.USD","LU1366334651.USD","LU0823437842.USD","03347","LU0828238088.HKD","LU1064130708.USD","BK0188","LU0231483743.USD","IE00B5MMRT66.SGD","LU2663582299.SGD","LU0955623706.USD","BK0012","LU1508157978.USD","LU1039395188.USD","SG9999001846.SGD","LU1568876335.HKD","06951","IE00BZ08YT58.USD","LU1146622755.USD","LU1997245177.USD","LU0862451753.SGD","IE00BZ08YR35.GBP","LU1655091616.SGD","BK0216","LU2097828557.USD","BK0183","IE00BZ08YS42.EUR","BK0014","IE00BZ199S13.USD","IE0032834883.USD","BK0174","LU0708995583.HKD","LU1997245094.SGD","LU1580142542.USD","LU2580892862.HKD","002827","IE0008368411.USD","IE00BPRC5H50.USD","300408","LU0791591158.USD","LU1655091459.SGD","000100","BK0017","LU1130305938.SGD","LU1366334578.USD","LU0320764599.SGD","LU1979443071.USD","LU0594300419.USD","LU2289578879.USD","BK0175","BK0126","LU1048484197.HKD","BK0030","IE00B0169N27.USD","LU0791590937.USD","LU1568876251.USD","IE0009570106.USD","IE0031814852.USD","LU1328615791.USD","LU2778985437.USD","SGXZ49509284.SGD","BK0086","LU0828237510.HKD","IE00B543WZ88.USD","LU0955648018.USD","300347","LU0264606111.USD","IE00B031HY20.USD","LU2476274308.USD","LU2097828714.EUR","BK0056","BK0070","LU1808992512.USD","LU0405327494.USD","IE0003795394.USD","LU2213484517.USD","LU0396098781.USD","LU2506952253.HKD","LU0650527681.SGD","BK0152","LU0117844026.USD","LU2148510915.USD","BK0214","LU0890818403.SGD","LU0509642566.USD","LU1675838814.USD","LU1255011170.USD","BK0229","IE0005HP3H50.USD","LU1997244956.HKD","LU2328871848.SGD","BK0224","LU0955669360.SGD","SGXZ81163826.USD","LU0784639295.USD","LU2097828631.EUR","LU1064131003.USD","LU0831103253.SGD","LU0228659784.USD","IE00B8HQ1Z84.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663791370","title":"泰格医药（300347）发布2026年A股限制性股票激励计划（草案），8月31日股价上涨5.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663791370","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663791370?lang=zh_cn&edition=full","pubTime":"2026-08-31 17:37","pubTimestamp":1788169053,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘，泰格医药报收于52.79元，较前一交易日上涨5.9%，最新总市值为454.54亿元。该股当日开盘49.64元，最高54.22元，最低49.0元，成交额达16.39亿元，换手率为5.51%。近日，泰格医药发布《2026年A股限制性股票激励计划（草案）》，拟授予513名激励对象950万股限制性股票，占公司总股本的1.103%。本计划有效期不超过60个月，设三个归属期，归属比例分别为40%、40%、20%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100024199.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","07233","159982","300347","82846","03347","LU1820825898.SGD","BK0174","83188","BK1583","03188","03130","BK1141","BK1576","LU1146622755.USD","BK0077","399300","BK1147","02846","BK0216","83130","02827"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155755037","title":"泰格医药：Schroders PLC增持，好仓比例升至7.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=1155755037","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1155755037?lang=zh_cn&edition=full","pubTime":"2026-08-31 17:32","pubTimestamp":1788168721,"startTime":"0","endTime":"0","summary":"Schroders PLC于2026年8月27日以每股均价40.2586港元买入泰格医药H股42.86万股，涉资约1725.48万港元。Schroders PLC此次增持前持有泰格医药好仓837.75万股，占比6.8%；增持后持股量为880.61万股，好仓比例升至7.15%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663707576","title":"8月31日泰格医药涨5.90%，兴全商业模式LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2663707576","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663707576?lang=zh_cn&edition=full","pubTime":"2026-08-31 16:44","pubTimestamp":1788165890,"startTime":"0","endTime":"0","summary":"证券之星消息，8月31日泰格医药涨5.90%，收盘报52.79元，换手率5.51%，成交量31.23万手，成交额16.39亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共85家，其中持有数量最多的公募基金为兴证全球基金的兴全商业模式LOF。兴全商业模式LOF的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100022445.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","300347","BK0174","03347","BK0077","BK1576","BK1583","LU1820825898.SGD","LU1146622755.USD","BK0216","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663022747","title":"港股异动 | 泰格医药(03347)逆势涨超5% 上半年扣非归母净利同比增三成 新签订单加速增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2663022747","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663022747?lang=zh_cn&edition=full","pubTime":"2026-08-31 14:05","pubTimestamp":1788156343,"startTime":"0","endTime":"0","summary":"泰格医药(03347)逆势涨超5%，为当前CRO板块中唯一飘红个股。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20260831/20260831140725_10388.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260831/20260831140725_10388.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489298.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["300347","BK0028","BK1576","KCAI","LU1146622755.USD","LU1820825898.SGD","BK0216","BK1583","VXUS","03347","BK0174","BK4585","BK0077","BK1141","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663042416","title":"股市必读：泰格医药中报 - 第二季度单季净利润同比下降312.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663042416","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663042416?lang=zh_cn&edition=full","pubTime":"2026-08-31 02:31","pubTimestamp":1788114669,"startTime":"0","endTime":"0","summary":"业绩披露要点财务报告泰格医药2026年中报显示，上半年度公司主营收入37.08亿元，同比上升14.06%；归母净利润-4.13亿元，同比下降207.78%；扣非净利润2.78亿元，同比上升31.78%；其中2026年第二季度，公司单季度主营收入19.06亿元，同比上升13.03%；单季度归母净利润-4.62亿元，同比下降312.15%；单季度扣非净利润1.57亿元，同比上升45.1%；负债率17.21%，投资收益-243.19万元，财务费用4228.46万元，毛利率27.53%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100000782.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300347","03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663273048","title":"泰格医药（300347）2026年中报简析：增收不增利，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2663273048","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663273048?lang=zh_cn&edition=full","pubTime":"2026-08-30 06:28","pubTimestamp":1788042533,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期泰格医药发布2026年中报。本报告期泰格医药公司应收账款体量较大，当期应收账款占最新年报归母净利润比达149.99%。本次财报公布的各项数据指标表现一般。持有泰格医药最多的基金为兴全商业模式LOF，目前规模为165.65亿元，最新净值5.099，较上一交易日下跌1.49%，近一年上涨15.68%。本文数据来源于泰格医药2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000003025.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","BK0077","BK0216","BK1583","03347","BK0174","LU1820825898.SGD","BK0028","300347","BK1576","LU1146622755.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166482479","title":"泰格医药拟调整12.30亿港元未动用H股募资用途 新增用于偿债及营运资金配置","url":"https://stock-news.laohu8.com/highlight/detail?id=1166482479","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166482479?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:23","pubTimestamp":1787927012,"startTime":"0","endTime":"0","summary":"2026年8月28日，杭州泰格医药科技股份有限公司公告称，公司董事会已审议通过“2026年变更H股发售所得款项用途”方案，拟重新分配目前尚未动用的1,230.3百万港元H股募资余额。经多次调整后，截至本次公告日，尚有1,230.3百万港元未被动用。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154647702","title":"泰格医药（03347.HK）拟注销588.38万股A股并下调注册资本 同步修订公司章程","url":"https://stock-news.laohu8.com/highlight/detail?id=1154647702","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154647702?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:22","pubTimestamp":1787926938,"startTime":"0","endTime":"0","summary":"2026年8月28日，泰格医药公告称，公司董事会已审议通过两项议案：一是拟注销回购的5,883,780股A股库存股份并相应减少注册资本；二是据此对公司章程进行相应修订。上述议案尚需提交公司2026年第三次临时股东大会及A、H股类别股东会议以特别决议方式审议通过后方可生效。此前，公司已累计回购9,806,300股A股，其中40%已于2026年5月29日注销；余下5,883,780股原拟用于后续股权激励或员工持股计划，本次拟全部改为注销并减少注册资本。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170687677","title":"泰格医药董事会通过2026年A股限制性股票激励计划　拟授950万股占总股本1.103%","url":"https://stock-news.laohu8.com/highlight/detail?id=1170687677","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170687677?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:15","pubTimestamp":1787926546,"startTime":"0","endTime":"0","summary":"2026年8月28日，杭州泰格医药科技股份有限公司公告称，公司董事会在当日召开的第六届董事会第二次会议上审议通过以下事项：一是建议采纳《2026年A股限制性股票激励计划》及其摘要；二是建议采纳《2026年A股限制性股票激励计划实施考核管理办法》；三是建议授权董事会办理该激励计划相关事宜。本次激励计划拟向513名激励对象一次性授予限制性股票950万股，占公告时公司总股本861,026,050股的1.103%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168718902","title":"泰格医药（03347）披露2026年A股限制性股票激励计划：拟授950万股 价格39.32元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=1168718902","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168718902?lang=zh_cn&edition=full","pubTime":"2026-08-28 21:17","pubTimestamp":1787923077,"startTime":"0","endTime":"0","summary":"2026年8月28日，杭州泰格医药科技股份有限公司在深交所网站公告《2026年A股限制性股票激励计划（草案）摘要》，并同步于香港发布海外监管公告。计划采用第二类限制性股票形式，股票来源为公司已回购的A股普通股。拟一次性向513名激励对象授予限制性股票950万股，占公告时公司总股本86,102.6050万股的1.103%。任一激励对象通过全部在有效期内的股权激励计划获授股份累计不超过公司总股本的1%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176671908","title":"泰格医药（03347）颁布《控股子公司管理制度》 加强对子公司治理与信息披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1176671908","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176671908?lang=zh_cn&edition=full","pubTime":"2026-08-28 21:17","pubTimestamp":1787923047,"startTime":"0","endTime":"0","summary":"泰格医药于2026年8月28日在香港刊发海外监管公告，并同步披露其于深圳证券交易所网站发布的《控股子公司管理制度》。该制度已由公司董事会于2026年8月29日审议通过，自公布之日起施行。控股子公司的发展战略须服从公司整体战略。控股子公司董事、高级管理人员不得兼任同一子公司的监事。泰格医药表示，该制度旨在通过完善对子公司的治理、财务监管及信息披露要求，提升整体运营效率与风险管理水平，并维护公司及投资者的合法权益。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164338920","title":"泰格医药（03347）披露章程修订  注册资本调降并优化治理架构","url":"https://stock-news.laohu8.com/highlight/detail?id=1164338920","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164338920?lang=zh_cn&edition=full","pubTime":"2026-08-28 21:16","pubTimestamp":1787923001,"startTime":"0","endTime":"0","summary":"泰格医药8月28日在香港联交所发布海外监管公告，披露公司将对《公司章程》相关条款进行修订，涉及注册资本、股本结构及公司治理架构等内容。此次修订已于深圳证券交易所网站披露，仅供参阅。以下为关键调整要点：。公司注册资本由人民币86,102.6050万元调整为人民币85,514.2270万元，减少588.3780万元。– 其中，境内上市内资股（A股）由737,901,250股调整为732,017,470股，占公司总股本比例由约85.70%降至约85.60%。本次章程修订的实施日期为2026年8月29日。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tigermed.net","stockEarnings":[{"period":"1week","weight":0.0117},{"period":"1month","weight":0.048},{"period":"3month","weight":0.2582},{"period":"6month","weight":-0.0968},{"period":"1year","weight":-0.1701},{"period":"ytd","weight":-0.0624}],"compareEarnings":[{"period":"1week","weight":0.0026},{"period":"1month","weight":-0.0102},{"period":"3month","weight":0.0276},{"period":"6month","weight":-0.0041},{"period":"1year","weight":0.0236},{"period":"ytd","weight":0.0008}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"杭州泰格医药科技股份有限公司是一家主要从事为新药研发提供临床试验全过程专业服务的中国公司。该公司提供服务主要包括临床试验技术服务和临床试验相关及实验室服务。临床试验技术服务提供创新药物、仿制药及医疗器械临床试验运营服务以及与临床试验直接相关的配套服务，包括临床运营、临床药理、注册与法规事务、科学事务等服务。临床试验相关及实验室服务提供在药物开发过程中的相关及实验室服务，包括数据管理及统计分析、临床试验现场管理、受试者招募、医学影像以及实验室等服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.032258},{"month":2,"riseRate":0.5,"avgChangeRate":0.003409},{"month":3,"riseRate":0.5,"avgChangeRate":-0.032695},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.051086},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.017912},{"month":6,"riseRate":0.666667,"avgChangeRate":0.042051},{"month":7,"riseRate":0.666667,"avgChangeRate":0.080461},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.061347},{"month":9,"riseRate":0.285714,"avgChangeRate":0.022415},{"month":10,"riseRate":0.5,"avgChangeRate":-0.025938},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.001369},{"month":12,"riseRate":0.5,"avgChangeRate":0.041242}],"exchange":"SEHK","name":"泰格医药","nameEN":"TIGERMED"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泰格医药(03347)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泰格医药(03347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泰格医药,03347,泰格医药股票,泰格医药股票老虎,泰格医药股票老虎国际,泰格医药行情,泰格医药股票行情,泰格医药股价,泰格医药股市,泰格医药股票价格,泰格医药股票交易,泰格医药股票购买,泰格医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泰格医药(03347)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泰格医药(03347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}